Back
Intellia Therapeutics, Inc. Stock Predictions
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
19
NTLA
Intellia Therapeutics, Inc.
Last Price:
$9.24
Seasonality Move:
-6.88%
7 Day Trial
ALL ACCESS PASS
$
7
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiIntellia Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Intellia Therapeutics, Inc. has on average historically risen by 20.4% based on the past 9 years of stock performance.
-
Intellia Therapeutics, Inc. has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Intellia Therapeutics, Inc. Stock Undervalued?The current Intellia Therapeutics, Inc. [NTLA] share price is $9.23. The Score for NTLA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
NTLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Intellia Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Intellia Therapeutics, Inc. has on average historically risen by 20.4% based on the past 9 years of stock performance.
Intellia Therapeutics, Inc. Stock Rating
Sell
19
Intellia Therapeutics, Inc. (NTLA)
is a Sell
Is Intellia Therapeutics, Inc. overpriced?
-
Intellia Therapeutics, Inc. has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Intellia Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
intelliatx.com
52-Week Data
52-Week High:
28.25
52-Week Low:
5.90
Prediction Charts
Market Cap:
1.1B
Price in USD:
9.23
Volume:
6.6M
Beta:
2.10
Technical Analysis
SMA50:
13.31
SMA100:
13.51
SMA200:
11.33
52-Wk Change:
-23.59%
Stock Predictions
-
Is Intellia Therapeutics, Inc. stock public?Yes, Intellia Therapeutics, Inc. is a publicly traded company.
-
What is the Intellia Therapeutics, Inc. stock quote today?The Intellia Therapeutics, Inc. stock price is 9.23 USD today.
-
How to buy Intellia Therapeutics, Inc. stock online?You can buy Intellia Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 8.43 | 8.10 | 8.49 | 8.09 |
| Dec-3 | 8.23 | 9.06 | 9.12 | 8.13 |
| Dec-4 | 8.91 | 9.74 | 9.92 | 8.85 |
| Dec-5 | 9.59 | 9.61 | 9.66 | 9.36 |
| Dec-8 | 9.89 | 9.44 | 9.95 | 9.35 |
| Dec-9 | 9.36 | 9.30 | 9.60 | 9.22 |
| Dec-10 | 9.27 | 9.37 | 9.70 | 9.15 |
| Dec-11 | 9.33 | 9.55 | 9.67 | 9.25 |
| Dec-12 | 9.61 | 9.02 | 9.68 | 9.02 |
| Dec-15 | 9.08 | 9.14 | 9.23 | 8.90 |
| Dec-16 | 9.00 | 9.12 | 9.26 | 8.91 |
| Dec-17 | 9.13 | 8.79 | 9.55 | 8.78 |
| Dec-18 | 8.94 | 8.88 | 9.16 | 8.74 |
| Dec-19 | 8.90 | 9.23 | 9.54 | 8.90 |
Intellia Therapeutics, Inc. Earnings
Intellia Therapeutics, Inc. Earnings Report: Per Share Intellia Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intellia Therapeutics, Inc. Forecast Revenue Growth
Intellia Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Intellia Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.31 per share, and an increase next year of $0.38 per share.
* Intellia Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.